Czech Republic – Infliximab 120 mg

By: Central Military Hospital - Military University Hospital Prague📍 Czech RepublicOpen

Key Information

ReferenceGB-738228-2026
DeadlineNov 26, 2026 12:00 AM
CategoryAdvertising & Media
Competition TypeICB
Funding SourceSelf-Funded
CountryCzech Republic
AddressAt the military hospital 1200/1, Prague - Břevnov, 16200, Czech Republic
PublishedOct 26, 2026

Description

2. Procedure2.1.ProcedureTitle: Infliximab 120 mgDescription: The subject of this public contract is the ongoing supply of a medicinal product with the medicinal substance INFLIXIMAB for the needs of ...

Full details are available after unlocking this tender.